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• Integration- The newly created 
HIV DNA moves into the T cell’s 
nucleus and is spit into the host 
DNA. Once the viral DNA is 
integrated with the host’s DNA, 
the DNA is replicated using 
normal replication mechanisms.  
• Transcription- Next, HIV uses T 
cells to make copies of the virus. 
The viral RNA is used as a 
template for new viruses and 
messenger RNA (mRNA).  The 
mRNA produces viral proteins 
with ribosomes in the cell 
cytoplasm.  Simultaneous 
production of other mRNA allows 
for translation of additional viral 
proteins, which leads to 
maturation of the HIV and an 
increased ability to infect the host.   
• Assembly- During assembly, viral 
proteins collect at the plasma 
membrane, and move together 
toward the cells surface.   
• Budding- When the virus reaches 
the cells surface, the virus breaks 
away from the host cell.  
• Maturation- The cell does not 
mature until the HIV protease 
enzyme, which was produced 
during integration, cuts the viral 
multiprotein chains into their 
proper size.  This leads to a 
mature and functional HIV virion 
that is able to infect other T cells, 
specifically T cells with the cell 
marker CD4.   
When the new virus leaves the CD4 T 
cell, the plasma membrane of the 
cell is ruptured and the CD4 cell is 
destroyed.  Over a period of years, 
HIV invades and destroys other T 
cells; the host immune system is 
weakened, which leads to the 
onset of AIDS (Moss, 2013).  
 
HIV is a member of the lentivirus 
genus.  These viruses are characterized 
by long latency period and progressive 
infection where the virus evades the 
immune response of the host.  HIV is 
transmitted through blood, semen, 
vaginal fluids, and breast milk.  HIV 
infects cells in the immune system and 
the central nervous system.  More 
specifically, HIV infects the CD4 T cells, 
also known as T lymphocytes.  T cells 
play a crucial role in the immune system 
to fight infection. Therefore, a significant 
reduction in T cells weakens the immune 
system.  HIV is comprised of two 
antigens that are specific to the virus, 
gylcoprotein 120 and 41 (gp120 and 
gp41).  These two antigens bind with 
immune cells to initiate the infectious 
cycle (Moss, 2013).    
In order for the virus to survive and 
replicate, the virus must go through 
multiple stages.   
• Attachment- HIV transmission 
begins with the HIV’s gp120 attaching to 
the T cell’s surface.   
• Penetration- After the virus is 
attached, the virus penetrates into the T 
cell.  Once inside, the capsid proteins are 
digested, releasing viral enzymes and 
RNA into the cytoplasm of the T cell.   
• Reverse Transcription- The HIV 
enzyme uses reverse transcriptase to 
transforms the viral RNA into single-
stranded DNA. It is common for errors 
to occur due to poor “proofreading” of 
the reverse transcriptase.  The process 
repeats to create a double-stranded 
DNA.   
  
In caring for a patient with HIV/AIDS, 
it is important for nurses to be educated 
on HIV transmission and understand the 
virus cannot be transmitted through 
common contact.  All body fluid should 
be considered as potentially infectious, 
and standard precautions should be 
maintained. Standard precautions 
include hand washing, use of personal 
protective equipment, and sharps 
handling and disposal (Koerich, dos 
Santos, Schlindwein Meirelles, & 
Erdmann, 2015). 
Thirty years ago, the human 
immunodeficiency virus (HIV) was 
recognized as the cause of acquired 
immune deficiency syndrome (AIDS).  
Since that time, HIV/AIDS continues to 
be an ongoing problem worldwide.  Even 
with persistent public heath campaigns 
and advancements in antiretroviral 
therapy, HIV/AIDS remains a major 
cause of global morbidity and mortality 
(Aggleton, Yankah, & Crewe, 2011).  
Although the annual number of new 
HIV/AIDS infections has remained 
stable, the number of people living with 
HIV/AIDS has continued increased.  In 
the United States alone, the Centers of 
Disease Control and Prevention (CDC) 
estimates that 1,201,100 people are 
living with HIV infection, in addition to 
168,300 (14%) who are unaware of 
being infected.  In 2013, an estimated 
47,352 people were diagnosed with HIV, 
while an estimated 26,688 people were 
diagnosed with AIDS (CDC, 2015).   
HIV/AIDS is disproportionately more 
common in certain countries and high-
risk groups.  Homosexual men, bisexual 
men, and intravenous drug users 
continue to endure the highest rates of 
HIV infection.  Homosexual men account 
for about 50% of people living with HIV, 
and intravenous drug users account for 
approximately 25% (Castel, Magnus, & 
Greenberg, 2015).  Racially, African 
American and Latinos account for 45% 
of new HIV infections.  However, 
globally, the epidemic is the most severe 
in South Africa.  South Africa holds more 
than half (70%) of the world’s HIV 
population.  Fortunately, since 2010, 
AIDS-related deaths have decreased 
steadily due to free drug treatment.  But, 
there has been a rapid increase in new 
HIV infections in other countries such as: 
India, China, Central Asia, Eastern 
Europe, and parts of Russia.  In Central 
Asia and China, the HIV rate as risen 
250% over the past 10 years (Moss, 
2013).   
Although HIV/AIDS infection has 
dropped about 20%, the incidence of 
infection varies in different parts of the 
world.  The variation in incidences points 
to flawed public perceptions that the 
dangers from HIV are declining as a 
result of treatment and educational 
programs.  Therefore, education and 
general public awareness are a main 
focus when it comes to decreasing the 
rate of HIV/AIDS.  
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Considerations  
Strategies for HIV/AIDS prevention 
and management evolve continually.  
Educational programs and treatment are 
becoming more effective and efficient.  
The only way to prevent new infections 
is through education.  HIV prevention 
programs are being implemented in 
nearly all countries (Moss, 2013).  In 
2011, the United Nations Program on 
HIV/AIDS (UNAIDS) mission included 
decreasing the sexual transmission of 
HIV by 50%, a 50% reduction in AIDS-
related maternal mortality, and the 
elimination of new infections via drug 
users and vertical transmission (Moss, 
2013).  With recent achievements and 
ambitious goal setting, a HIV-free 
generation is possible.  
Conclusion  
At this time there is no cure for HIV.  But 
with antiretroviral therapy, the course of 
HIV can be altered.  Enhancements in 
treatments have led to fewer HIV-infected 
individuals dying of HIV-related illnesses 
(Millard, Elliott, & Girdler, 2013).  Currently, 
there are more than 20 approved 
antiretroviral drugs.  These drugs aim to 
maintain the HIV levels to prevent 
weakening of the immune system.  
Combination therapy is when the patient is 
taking 2 or more antiretrovirals at the same 
time.  Taking 3 or more antiretrovirals is 
called highly active antiretroviral therapy 
(HAART).  HAART has become the standard 
of care in high-income countries.  Regimes 
normally contain a drug to suppress viral 
replication, and a drug to increase CD4 
lymphocyte counts.  Patient must receive 
treatment for life.  Negative effects of long-
term treatment include diabetes, heart 
disease, liver disease, and various forms of 
cancer.  Although, there is no cure, 
antiretrovirals have to possibility to turn 
HIV/AIDS into a long-term chronic medical 
condition (Moss, 2013).  
Treatment 
Signs and Symptoms 
HIV occurs in four stages: primary infection, clinically asymptomatic HIV, 
possible minor symptoms, and symptomatic HIV.  
 
• Stage I-  The first stage of infection only last for a couple of months, it is 
common for the infected person to experience no symptoms or have a brief period 
of flu-like illness (AIDS.gov, 2015).  During this time, there is a high amount of HIV 
in the blood, and the immune system responds to the virus by generating HIV 
antibodies and cytotoxic lymphocytes.  The process of creating antibodies to a 
specific antigen is called seroconversion (Moss, 2015).   
 
• Stage II- After seroversion is complete, the infected person will test positive for 
HIV.  The clinically asymptomatic HIV last an average of 10 years.  The individual 
usually has no symptoms, except the person may have swollen glands and may 
develop psoriasis, shingles, and minor infections.  After a prolonged asymptomatic 
phase, symptoms begin to show in the infected person (Moss, 2015).  
 
• Stage III-  In the symptomatic HIV phase, HIV has significantly damaged the 
individual’s immune system.  When lymphocyte counts drop to below 200 
cells/uL, the person is at risk for multiple infections.  Opportunistic infections can 
include: pneumonia, diarrhea, eye infections, and meningitis.  Having a severely 
weakened immune system also increase the risk for various cancers.  It is common 
for the individual to develop HIV wasting syndrome, which is characterized by 
rapid weight loss and weakness (Moss, 2013).  
 
• Stage IV-  As the immune system become increasingly impaired, the individual 
will progress to AIDS.  The symptomatic stage progressing to AIDS lasts from 8 to 
12 years (Moss, 2013). 
The average detection window for HIV 
testing is 25 to 30 days after infection.  If an 
infected person is using antiretroviral 
therapy, antibody formation can be delayed 
up to 12 months.  A diagnosis of HIV can be 
confirmed with several different types of 
tests.  These tests are designed to detect 
antigens, antibodies, or RNA.  The original 
screening test was used to determine the 
presences of enzyme-linked immunosorbent 
assay (ELISA).  The ELISA test is a two-step 
process used to check for antibodies 
stimulated by HIV.  If the ELISA generates a 
positive result, a conformation test is usually 
performed.  According to the CDC, the ELISA 
method is not used to confirm a diagnosis.  
The CDC recommends using the more 
expensive Western blot test.  The Western 
blot test also identifies antibodies, but it 
identified antibodies of specific molecular 
weight, which eliminates false-positive 
results.  Other tests available are rapid tests 
that provide a result within 10 to 20 
minutes, or at home tests using an oral 
swab.  However, any positive result needs to 
be confirmed by a Western blot test (Moss, 
2013).  
